S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial

被引：0
|
作者：
Yong Wha Moon
Soohyeon Lee
Byeong-Woo Park
Eun-Kyung Kim
Seung Il Kim
Ja Seung Koo
Seho Park
Min Jung Kim
Hyun Cheol Chung
Joo-Hang Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Yonsei Cancer Center, Divison of Medical Oncology, Department of Internal Medicine
[2] Yonsei University College of Medicine,Department of General Surgery
[3] Yonsei University College of Medicine,Department of Radiology
[4] Yonsei University College of Medicine,Department of Pathology
[5] The University of Texas MD Anderson Cancer Center,undefined
来源：
BMC Cancer | / 13卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; S-1; Docetaxel; Pathological complete response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
    Moon, Yong Wha
    Lee, Soohyeon
    Park, Byeong-Woo
    Kim, Eun-Kyung
    Kim, Seung Il
    Koo, Ja Seung
    Park, Seho
    Kim, Min Jung
    Chung, Hyun Cheol
    Kim, Joo-Hang
    Sohn, Joohyuk
    [J]. BMC CANCER, 2013, 13 : 1 - 7
  • [2] A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
    Schneeweiss, A.
    Marme, F.
    Ruiz, A.
    Manikhas, A. G.
    Bottini, A.
    Wolf, M.
    Sinn, H. -P.
    Mansouri, K.
    Kennedy, L.
    Bauknecht, T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 609 - 617
  • [3] Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
    Jones, Stephen E.
    Savin, Michael A.
    Holmes, Frankie Ann
    O'Shaughnessy, Joyce A.
    Blum, Joanne L.
    Vukelja, Svetislava
    McIntyre, Kristi J.
    Pippen, John E.
    Bordelon, James H.
    Kirby, Robert
    Sandbach, John
    Hyman, William J.
    Khandelwal, Pankaj
    Negron, Angel G.
    Richards, Donald A.
    Anthony, Stephen P.
    Mennel, Robert G.
    Boehm, Kristi A.
    Meyer, Walter G.
    Asmar, Lina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5381 - 5387
  • [4] Phase II trial of docetaxel plus doxorubicin and cyclophosphamide in locally advanced breast cancer (LABC).
    Puertolas, T
    Grandez, R
    de Lobera, AR
    Lao, J
    Herrero, A
    Trufero, JM
    Pazo, R
    Orduña, VA
    Cortes, AA
    Torres, AA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 89S - 89S
  • [5] Phase II trial report of the new neoadjuvant chemotherapy with S-1 and docetaxel for advanced breast cancer
    Okazaki, K.
    Kira, M.
    Yamai, H.
    Nakagawa, Y.
    Nagao, T.
    Kenzaki, K.
    Bando, Y.
    Morimoto, T.
    Kondo, K.
    Tangoku, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A phase II trial of docetaxel plus carboplatin plus bevacizumab as neoadjuvant therapy for triple negative breast cancer
    Chacon Lopez-Muniz, J. I.
    Cardenas, J. D.
    Santos Rodriguez, A. K.
    Esteban Esteban, M. C.
    Munoz Platon, E.
    Rubio Salvador, A. R.
    Alonso Soler, S. E.
    Fernandez Franco, L.
    San Juan del Moral, A.
    Burgueno Lorenzo, I.
    Trujillo Alba, B. L.
    Martinez Moreno, E.
    Moya Gomez, P.
    Cruz Mora, M. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
  • [7] Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer:: A randomized phase II trial
    Schneeweiss, Andreas
    Lauschner, Ilka
    Ruiz, Amparo
    Guerrero, Angel
    Sanchez-Rovira, Pedro
    Segui, Miguel Angel
    Goerke, Kay
    Wolf, Michael
    Manikhas, Alexey G.
    Wacker, Juergen
    Marme, Frederik
    Lichter, Peter
    Sinn, Hans-Peter
    Sohn, Christof
    Mansouri, Kambiz
    Bauknecht, Thomas
    Hahn, Meinhard
    [J]. CLINICAL BREAST CANCER, 2007, 7 (07) : 555 - 558
  • [8] A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
    Yoo, Changhoon
    Kim, Sung-Bae
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Jung, Kyung Hae
    Gong, Gyung-Yub
    Son, Byung-Ho
    Ahn, Sei-Hyun
    Ahn, Seung Do
    Kim, Hak-Hee
    Shin, Hee Jung
    Kim, Woo Kun
    [J]. CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 406 - 415
  • [9] Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide plus /- Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)
    Tuxen, M. K.
    Cold, S.
    Tange, U. B.
    Soendergaard, S. B.
    Nielsen, D. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S173 - S173
  • [10] A phase II trial of neoadjuvant docetaxel/cyclophosphamide followed by epirubicin/cyclophosphamide for triple-negative breast cancer
    Tanaka, N.
    Hirano, A.
    Inoue, H.
    Ogura, K.
    Hattori, A.
    Jibiki, N.
    Yukawa, H.
    Matsuoka, A.
    Kodera, A.
    Kamimura, M.
    Naritaka, Y.
    Shimizu, T.
    [J]. CANCER RESEARCH, 2017, 77
12345